ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,116 | +41.3% | 3,059 | +12.0% | 0.97% | +51.2% |
| Q2 2023 | $1,064,795 | +5.3% | 2,732 | +0.7% | 0.64% | -0.2% |
| Q1 2023 | $1,010,849 | +7.9% | 2,713 | +9.7% | 0.64% | -1.5% |
| Q4 2022 | $936,697 | +12.3% | 2,473 | +4.7% | 0.65% | +9.2% |
| Q3 2022 | $834,000 | -30.5% | 2,361 | -25.4% | 0.60% | -29.8% |
| Q2 2022 | $1,200,000 | +24.5% | 3,167 | +3.6% | 0.85% | +40.1% |
| Q1 2022 | $964,000 | +67.4% | 3,057 | +86.1% | 0.61% | +78.6% |
| Q4 2021 | $576,000 | +24.4% | 1,643 | +7.1% | 0.34% | +13.7% |
| Q3 2021 | $463,000 | -40.0% | 1,534 | -55.3% | 0.30% | -60.7% |
| Q2 2020 | $772,000 | +43.8% | 3,428 | -15.9% | 0.76% | +18.6% |
| Q1 2020 | $536,692 | -28.8% | 4,074 | -13.2% | 0.64% | -11.5% |
| Q4 2019 | $754,000 | – | 4,694 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |